Login
$CTMX
$2.23 -$0.09 (4.09%) Close

Company Executives

$CTMX Management Team

Dr. Sean Mccarthy

Chairman of the Board

Chief Executive Officer

Age 58
Compensation $1.753M USD
Sex Male

Mr. Christopher Ogden

Senior Vice President

Chief Financial Officer

Assistant Secretary

Age 41
Compensation $914.3K USD
Sex Male

Dr. Yu-Waye Chu

Senior Vice President

Chief Medical Officer

Age 57
Compensation $808.4K USD
Sex Male

Ms. Rachael Lester

Senior Vice President

Chief Business Officer

Age -
Compensation -
Sex Female
Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
6.3 years
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2025 pay Source
James R. Meyers
Not stated 2018
8 years
Independent None stated Sangamo Therapeutics, Inc. $139,514
Halley Gilbert
Not stated 2020
6 years
Independent
Audit
Arcutis Biotherapeutics, Inc., Vaxcyte, Inc. $143,014
Alan Ashworth, Ph.D.
Not stated 2021
5 years
Independent
Nominating and Corporate Governance
None stated $131,514
Elaine V. Jones, Ph.D.
Not stated Not stated Independent
Compensation Nominating and Corporate Governance
None stated $137,514
Sean A. McCarthy, D. Phil.
Not stated Not stated Not independent None stated None stated Not stated
Mani Mohindru, Ph.D.
Not stated Not stated Independent
Audit
None stated $136,514
Matthew P. Young
Not stated Not stated Independent None stated None stated $167,514
Zhen Su, M.D., M.B.A.
Not stated Not stated Independent
Compensation
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support